Study at a glance
Why can the usual vitamin D test and the active vitamin D test give different results?
This page asks why two vitamin D blood tests can give different results. The usual test measures 25-hydroxyvitamin D, the main form available for conversion into active vitamin D. Another test measures 1,25-dihydroxyvitamin D, the active hormone. Kidney function and other hormones help control the active form.
Who was studied to compare the two vitamin D blood tests?
The page combines research reviews with a study of patient records. Researchers examined 319 patients with low 25-hydroxyvitamin D and compared groups with different levels. They measured active vitamin D, calcium absorption and parathyroid hormone, which helps control calcium.
How did active vitamin D levels change when the usual vitamin D test was low?
Active vitamin D and calcium absorption were maintained across much of the low-vitamin-D range while parathyroid hormone rose. The hormone can help the kidneys make more active vitamin D. In the group with 25-hydroxyvitamin D at 10 nmol/L or below, active vitamin D and calcium absorption fell. The body’s ability to maintain active vitamin D was therefore limited.
Can active vitamin D stay normal when the usual blood test shows low vitamin D?
Normal active vitamin D does not rule out low 25-hydroxyvitamin D. Low active vitamin D can also reflect kidney or hormone problems, rather than low vitamin D intake alone. The patient study looked back at records from a particular group of patients. Its 10 nmol/L finding does not set a treatment threshold for everyone, and neither blood test measures all vitamin D effects in tissues.
Read the full article below ↓25-hydroxyvitamin D and 1,25-dihydroxyvitamin D are related metabolites, but they are not interchangeable blood markers. 25(OH)D mainly reflects the circulating vitamin D substrate pool and is the standard marker used when vitamin D status is being assessed. 1,25(OH)₂D is the active endocrine hormone and is regulated tightly by the kidney, PTH, FGF23 and feedback.
What question did this evidence investigate?
The evidence asks why the two metabolites can give apparently different messages and what each concentration actually represents. The key issue is whether active-hormone concentration simply tracks vitamin D stores, or whether homeostatic regulation can separate the two.
What was studied?
The evidence combines clinical laboratory reviews, mechanistic reviews of renal regulation, and a primary clinical study by Need and colleagues. In that study, 319 patients with 25(OH)D at or below 40 nmol/L were identified from 3,661 patient records and grouped by the severity of low 25(OH)D.
What did the researchers find?
Across much of the low-25(OH)D range, serum 1,25(OH)₂D and calcium absorption were maintained while PTH rose. This supports a homeostatic explanation: increased PTH can stimulate renal activation and defend active hormone even while the 25(OH)D substrate pool is reduced. In the most severely depleted group, at 10 nmol/L 25(OH)D or below, 1,25(OH)₂D and calcium absorption fell, showing that compensation is not unlimited.
Mechanistic evidence explains the wider pattern. Renal CYP27B1 is stimulated by PTH and restrained by FGF23 and feedback from 1,25(OH)₂D, while CYP24A1 contributes to degradation. By contrast, hepatic production of 25(OH)D is less tightly regulated and more closely reflects substrate availability.
What does this evidence support?
It supports using 25(OH)D, rather than 1,25(OH)₂D, as the ordinary marker of vitamin D status when status testing is clinically indicated. It also supports the apparently counterintuitive possibility that someone can have low 25(OH)D while circulating active hormone remains normal. A normal 1,25(OH)₂D result therefore does not establish adequate vitamin D status.
What does this evidence not establish?
It does not show that 1,25(OH)₂D is always normal or high in deficiency. Severe substrate depletion, impaired renal activation and altered mineral-endocrine regulation can lower it. It also does not show that 25(OH)D measures tissue-level vitamin D effect. Local activation and receptor responses are not captured fully by either circulating number.
Why a normal active-hormone result can be misleading
The active hormone is not a passive downstream reflection of the 25(OH)D pool. PTH can increase conversion when mineral physiology demands it, while FGF23 and feedback can restrain production. This means the body can preserve the active-hormone concentration by changing regulatory effort. A normal 1,25(OH)₂D result can therefore coexist with a low status marker and should not be used to rule out low 25(OH)D.
The reverse also matters. Low 1,25(OH)₂D can arise when renal activation is impaired or when endocrine regulation is altered. It is not automatically evidence of nutritional vitamin D deficiency. The metabolite has to be interpreted as a regulated hormone rather than as a second version of the same status test.
Why kidney regulation matters
The kidney is the main source of circulating 1,25(OH)₂D, so renal function and mineral hormones can alter the active-hormone result independently of vitamin D supply. This is why Vitamin D and Kidneys is relevant when the two biomarkers appear discordant.
What are the main limitations?
The primary severe-deficiency study was retrospective and came from a clinical referral population, so its approximate 10 nmol/L transition should not be turned into a universal treatment threshold. Its value is physiological: it demonstrates that compensation can preserve active hormone across substantial substrate depletion and that this compensation can eventually fail. The broader regulatory interpretation is strengthened by mechanistic and clinical laboratory reviews rather than resting on that one dataset alone.
Assay method also matters. 25(OH)D and especially 1,25(OH)₂D can be affected by analytical limitations, so an unexpected result needs to be interpreted with the method and clinical context in mind rather than treated as a pure readout of biology.
Why this matters within vitamin D physiology
The practical distinction is between a status/substrate marker and a regulated hormone. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D provides the wider testing framework, while Free vs Total Vitamin D Explained addresses another measurement distinction involving binding and circulating fractions.
For the deeper evidence review, see 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Physiological Meaning and Regulation: Full Study.
Primary evidence and source details
Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency. Need AG et al. Journal of Bone and Mineral Research. 2008;23:1859 to 1863.
The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine. Dirks NF et al. Nutrients. 2018;10:482.
Vitamin D Assays. Bikle DD. Frontiers of Hormone Research. 2018;50:14 to 30.
Related reading
Paradoxical Elevation of Parathyroid Hormone Levels following Preoperative Native Vitamin D Supplementation in a Patient with Graves’ Disease Undergoing Total Thyroidectomy: A Case Report
Hypocalcemia is a common complication after total thyroidectomy, particularly in patients with Graves’ disease and high bone turnover.
Original paper ↗Read more →Vitamin D and the promoter methylation of its metabolic pathway genes in association with the risk and prognosis of tuberculosis
The specific methylation profiles were examined as epigenetic biomarkers.
Original paper ↗Read more →Vitamin D Status and Indices of Mineral Homeostasis in the Population: Differences Between 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D
This population-based study investigated cross-sectionally the associations of 25-hydroxyvitamin D (calcidiol) and 1,25-dihydroxyvitamin D (calcitriol) with indices of mineral homeostasis.
Original paper ↗Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Serum phosphate levels modify the impact of parathyroid hormone levels on renal outcomes in kidney transplant recipients
To date, data simultaneously evaluating these parameters and interwoven relations on renal outcomes are scarce.
Original paper ↗Read more →Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease
Here, we examined the effects of Fgfr1: 3, αKlotho, or Fgfr1: 4 ablation specifically in the PG (conditional knockout, cKO).
Original paper ↗Read more →Gender specific association of parathyroid hormone and vitamin D with metabolic syndrome in population with preserved renal function
The association of parathyroid hormone (PTH) and vitamin D with Metabolic syndrome (MetS) was evaluated using representative data from the Korean population.
Original paper ↗Read more →Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis
However, evidence of the causal role of mineral metabolism in CAVS is still lacking.
Original paper ↗Read more →Tubular functional capacity and maladaptive parathyroid hormone response in early-stage chronic kidney disease
TFC was evaluated by measuring effective renal plasma flow (mERPF, mL/min/1.73m2) using (131I) Hippurate (131I-H) clearance, while GFR was measured using (99m) Tc-DTPA (mGFR, mL/min/1.73m2).
Original paper ↗Read more →Vitamin D Status among Thai School Children and the Association with 1,25-Dihydroxyvitamin D and Parathyroid Hormone Levels
Only 4% (21 of 529) participants had a serum 25(OH)D level below 50 nmol/L.
Original paper ↗Read more →Why Normal 1,25-Dihydroxyvitamin D Does Not Rule Out Low Vitamin D Status
Learn why normal 1,25-dihydroxyvitamin D does not rule out low vitamin D status and how hormonal regulation can preserve active vitamin D levels.
Read more →Association between 25-Hydroxyvitamin D, Parathyroid Hormone, Vitamin D and Calcium Intake, and Bone Density in Healthy Adult Women: A Cross-Sectional Analysis from the D-SOL Study
This cross-sectional analysis aimed to investigate the associations of 25(OH)D and plasma PTH concentrations with bone parameters, and potential confounders, in women living in a high (England) or low (Brazil) latitude country.
Original paper ↗Read more →The Role of Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone in Irritable Bowel Syndrome: A Bidirectional Two-Sample Mendelian Randomization Study
Therefore, we aimed to explore the bidirectional causal effects among serum calcium, Vit-D, PTH, and IBS at the genetic level by a two-sample Mendelian randomization (MR) analysis of the datasets from IEU OpenGWAS database.
Original paper ↗Read more →Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers
Serum Ca and 1,25(OH)2D were increased in Ca stone-formers compared to controls (P = 0.01 and P = 0.001).
Original paper ↗Read more →Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
Serum calcium, phosphate, alkaline phosphatase,parathyroid hormone, FGF-23, 25(OH)D, 1,25(OH)2D and Fractional excretion of phosphorous were assessed and compared between the two groups, using SPSS software.
Original paper ↗Read more →Associations of Vitamin D Deficiency, Parathyroid hormone, Calcium, and Phosphorus with Perinatal Adverse Outcomes. A Prospective Cohort Study
We aimed to evaluate the association of vitamin D deficiency during early pregnancy with preterm birth.
Original paper ↗Read more →Changes in the Calcium-Parathyroid Hormone-Vitamin D Axis and Prognosis for Critically Ill Patients: A Prospective Observational Study
Vitamin D deficiency is prevalent in critically ill patients and may contribute to suboptimal clinical outcomes, but little is known about alterations of the calcium-parathyroid hormone (PTH)-vitamin D axis and prognosis in these individuals.
Original paper ↗Read more →Interactions between Vitamin D Status, Calcium Intake and Parathyroid Hormone Concentrations in Healthy White-Skinned Pregnant Women at Northern Latitude
Little explored in pregnancy, we aimed to examine the relative importance of serum 25-hydroxyvitamin D (25(OH)D) and calcium intake on parathyroid hormone (PTH) concentrations in healthy white-skinned pregnant women.
Original paper ↗Read more →1,25-Dihydroxyvitamin D to PTH(1 to 84) Ratios Strongly Predict Cardiovascular Death in Heart Failure
Here, the association of 1,25(OH)2D and PTH(1 to 84) levels was evaluated for prediction of cardiovascular death in chronic HF patients.
Original paper ↗Read more →Association of 1,25 dihydroxyvitamin D with left ventricular hypertrophy and left ventricular diastolic dysfunction in patients with chronic kidney disease
In the current study, we investigated the association between 1,25-dihydroxyvitamin D [1,25(OH)2D], the active form of 25(OH)D, and LVH/LVDD in CKD patients.
Original paper ↗Read more →Context-Dependent Association Between Serum 25-Hydroxyvitamin D and Romosozumab Bone Mineral Density Response: A Stratified Analysis by Renal Function Category and Prior Treatment History in a Real-World Japanese Cohort
This study investigated whether the renal function category and prior treatment history modified the association between baseline 25OHD and romosozumab BMD response.
Original paper ↗Read more →Original sources
Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency
Published in Need AG et al. Journal of Bone and Mineral Research (2008).
Publication details
Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency. Need AG et al. Journal of Bone and Mineral Research. 2008;23:1859 to 1863.
The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine
We now have the ability to measure a number of different vitamin D metabolites with very accurate methods.
Publication details
The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine. Dirks NF et al. Nutrients. 2018;10:482.
Vitamin D Assays
Published in Bikle DD. Frontiers of Hormone Research (2018).
Publication details
Vitamin D Assays. Bikle DD. Frontiers of Hormone Research. 2018;50:14 to 30.